Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Cianna Medical Inc.

Division of Merit Medical Systems Inc.

Latest From Cianna Medical Inc.

Execs On The Move, May 2017

Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Appointments BioPharmaceutical

Innovation In The Age Of Breast-Conserving Surgery

Medical device and diagnostic companies are developing innovative new products for women with breast cancer designed to facilitate earlier diagnosis, improve diagnostic accuracy, increase surgical precision, and enable the least invasive, most breast-conserving approach to breast cancer surgery. With the number of breast cancer cases in the US projected to increase dramatically by 2030, the success of these technologies depends on their ability to improve cosmetic results and survival rates while lowering overall health care costs.

Medical Device Innovation

Focal Therapeutics: 3-D Bioabsorbable Tissue Marker For Breast Lumpectomy

A three-dimensional soft-tissue marker for use during breast cancer surgery is now in clinical use and has been shown to shorten the number of radiation treatments and spare dosing of normal tissue. The spiral BioZorb tissue marker from start-up Focal Therapeutics Inc. is used primarily during lumpectomy procedures and is placed following removal of the tumor and prior to radiation therapy.

Medical Device

The Evolving World Of Breast Cancer Management

The device industry is playing a pivotal role in the evolution toward a more personalized approach to breast cancer management, with ongoing advances in minimally invasive treatment systems, tumor characterization and breast imaging technologies adding to the momentum. In the years ahead, as the breast cancer toolbox expands, the watchword will be “choice,” with physicians and patients offered more treatment options, targeted to their specific needs and desires, than ever before.

Medical Device Surgical Procedures
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Merit Medical Systems Inc.
  • Senior Management
  • Jill Anderson, Pres. & CEO
    Gordon Busenbark, CFO
    Eduardo Chi Sing, CTO
    Mike Numamoto, VP, Mktg.
  • Contact Info
  • Cianna Medical Inc.
    Phone: (949) 360-0059
    6 Journey
    Suite 125
    Aliso Viejo , CA 92656